City

Augusta (1)

Chesterfield (1)

Clovis (1)

Columbia (1)

Gainesville (1)

Jonesboro (1)

Louisville (1)

Nashville (1)

Portland (1)

Condition

Infusion Reaction (4)

Monoclonal Antibody (1)

Multiple Sclerosis (1)

Oncology (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Isala (1)

Providence Health & Services (1)

SCRI Development Innovations, LLC (1)

University of California, San Francisco (1)

Collaborator

Amgen (1)

Genentech, Inc. (1)

Intervention

antihistamine (1)

atezolizumab (1)

bevacizumab (1)

durvalumab (1)

ipilimumab (1)

montelukast 10 mg oral tablet (1)

nivolumab (1)

pembrolizumab (1)

trastuzumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (4)

Study Type

Interventional (3)

Observational (1)

infusion reaction

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting

Oncology
Infusion Reaction

Nivolumab
+6 more

(no location specified)

Sep 8, 2023

Multiple Sclerosis, Infusion Reaction Trial in Portland (antihistamine)

Active, not recruiting

Multiple Sclerosis
Infusion Reaction

antihistamine

Portland, Oregon

Providence Neurological Specialties West

Jan 10, 2022

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting

Infusion Reaction
Monoclonal Antibody

Montelukast 10 Mg Oral Tablet

Clovis, California

Community Cancer Institute

Nov 8, 2021

Infusion Reactions Due to Vectibix

Completed

Infusion Reaction

Jonesboro, Arkansas
+6 more

Aug 27, 2015